Connection

Alessandro Rambaldi to Combined Modality Therapy

Back to Details
This is a "connection" page, showing publications Alessandro Rambaldi has written about Combined Modality Therapy.
Alessandro Rambaldi
Connection Strength
0.129
Combined Modality Therapy
  1. Randomized Trial Comparing R-CHOP Versus High-Dose Sequential Chemotherapy in High-Risk Patients With Diffuse Large B-Cell Lymphomas. J Clin Oncol. 2016 11 20; 34(33):4015-4022.
    View in: PubMed
    Score: 0.084
  2. Cord blood-derived cytokine-induced killer cells combined with blinatumomab as a therapeutic strategy for CD19+ tumors. Cytotherapy. 2018 08; 20(8):1077-1088.
    View in: PubMed
    Score: 0.024
  3. Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia. N Engl J Med. 2017 03 02; 376(9):836-847.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.